Results for tag: "Plant Based Biomanufacturing"

Plant-based biomanufacturing refers to the use of plant systems to produce biopharmaceuticals, chemicals, and materials that are traditionally produced through conventional industrial processes. This branch of biotechnology exploits the natural capabilities of plants to synthesize complex molecules, providing an alternative to traditional cell-based systems such as bacteria, yeast, or mammalian cells. Plant-based systems offer the potential for scalability, reduced risk of pathogen contamination, and lower production costs, coupled with the benefits of post-translational modifications that are specific to eukaryotes. These systems can be used to manufacture a variety of products, including vaccines, antibodies, enzymes, and specialty chemicals. This method of production often involves genetic engineering to introduce new traits or pathways into plants, enabling them to produce the desired compounds. Once the plants are harvested, the product is extracted and purified. One of the key differences between plant-based systems and other expression systems is that the entire plant can act as a bioreactor, rather than relying on a single-cell culture. This field has witnessed growth in research advancements, and a focus on sustainability as it leverages photosynthesis, a renewable energy source, reducing the environmental footprint typically associated with industrial production. Notable companies in the plant-based biomanufacturing market include Medicago, which specializes in producing vaccines and therapeutic proteins in plants; Kentucky BioProcessing, which focuses on developing plant-expressed pharmaceuticals; and iBio, Inc., a firm that uses plant-based technologies for vaccine and therapeutic Show Less Read more